30347750|t|Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide.
30347750|a|Lack of endothelial nitric oxide causes endothelial dysfunction and circulating monocyte infiltration, contributing to systemic atheroma plaque formation in arterial territories. Among the different inflammatory products, macrophage-derived foam cells and smooth muscle cells synthesize matrix metalloproteinases (MMPs), playing a pivotal role in early plaque formation and enlargement. We found increased levels of MMP-9 and MMP-13 in human endarterectomies with advanced atherosclerosis, together with significant amounts of extracellular matrix (ECM) metalloproteinase inducer EMMPRIN. To test whether the absence of NO may aggravate atherosclerosis through EMMPRIN activation, double NOS3/apoE knockout (KO) mice expressed high levels of EMMPRIN in carotid plaques, suggesting that targeting extracellular matrix degradation may represent a new mechanism by which endothelial NO prevents atherosclerosis. Based on our previous experience, by using gadolinium-enriched paramagnetic fluorescence micellar nanoparticles conjugated with AP9 (NAP9), an EMMPRIN-specific binding peptide, magnetic resonance sequences allowed non-invasive visualization of carotid EMMPRIN in NOS3/apoE over apoE control mice, in which atheroma plaques were significantly reduced. Taken together, these results point to EMMPRIN as a new therapeutic target of NO-mediated protection against atherosclerosis, and NAP9 as a non-invasive molecular tool to target atherosclerosis.
30347750	73	80	EMMPRIN	Gene	12215
30347750	115	130	Atherosclerosis	Disease	MESH:D050197
30347750	157	169	Nitric Oxide	Chemical	MESH:D009569
30347750	191	203	nitric oxide	Chemical	MESH:D009569
30347750	299	307	atheroma	Disease	MESH:D058226
30347750	370	382	inflammatory	Disease	MESH:D007249
30347750	587	592	MMP-9	Gene	4318
30347750	597	603	MMP-13	Gene	4322
30347750	607	612	human	Species	9606
30347750	644	659	atherosclerosis	Disease	MESH:D050197
30347750	751	758	EMMPRIN	Gene	682
30347750	808	823	atherosclerosis	Disease	MESH:D050197
30347750	832	839	EMMPRIN	Gene	12215
30347750	859	863	NOS3	Gene	18127
30347750	883	887	mice	Species	10090
30347750	913	920	EMMPRIN	Gene	12215
30347750	924	939	carotid plaques	Disease	MESH:D016893
30347750	1063	1078	atherosclerosis	Disease	MESH:D050197
30347750	1123	1133	gadolinium	Chemical	MESH:D005682
30347750	1223	1230	EMMPRIN	Gene	12215
30347750	1332	1339	EMMPRIN	Gene	12215
30347750	1343	1347	NOS3	Gene	18127
30347750	1371	1375	mice	Species	10090
30347750	1386	1402	atheroma plaques	Disease	MESH:D058226
30347750	1470	1477	EMMPRIN	Gene	682
30347750	1540	1555	atherosclerosis	Disease	MESH:D050197
30347750	1609	1624	atherosclerosis	Disease	MESH:D050197
30347750	Negative_Correlation	MESH:D058226	12215
30347750	Association	MESH:D050197	4322
30347750	Negative_Correlation	MESH:D009569	12215
30347750	Positive_Correlation	MESH:D009569	MESH:D058226
30347750	Association	MESH:D050197	12215
30347750	Negative_Correlation	MESH:D009569	MESH:D050197
30347750	Association	MESH:D050197	682
30347750	Positive_Correlation	MESH:D050197	4318
30347750	Association	MESH:D016893	18127
30347750	Association	MESH:D005682	12215
30347750	Negative_Correlation	MESH:D009569	682
30347750	Association	MESH:D016893	12215

